Results 11 to 20 of about 178,848,266 (217)
Medication-related osteonecrosis of the jaw [PDF]
Revista Brasileira de Odontologia, 2018 .
Heliton Spindola Antunes +5 more
core +5 more sources
RANK-Ligand inhibitor associated osteonecrosis of the jaw
GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW, 2013 Osteonecrosis of the jaw may be caused by many different triggers. One of them is described to be the drug or medication related osteonecrosis of the jaw. Since many years bisphosphonates induced the dreaded diagnosis.
Rashad, Ashkan +2 more
doaj +2 more sources
Romosozumab-associated medication-related osteonecrosis of the jaw
Oral and Maxillofacial Surgery Cases, 2023 This is the first reported case of medication-related osteonecrosis of the jaw (MRONJ) resulting from the use of romosozumab, a new anti-resorptive medication that functions through inhibition of sclerostin.
Benjamin Palla +4 more
doaj +2 more sources
Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw [PDF]
Applied Sciences, 2021 Medication-related osteonecrosis of the jaw (MRONJ) has been associated with the use of different drugs administered in the treatment of malignant neoplasms or metastases and in antiresorptive therapies. Since 2010, denosumab, a monoclonal antibody whose
Sandra Bacián Martínez +13 more
doaj +2 more sources
Medication‐related osteonecrosis of the jaw – a current review [PDF]
Oral Surgery, 2018 AbstractAimThis study was aimed to discuss different classes of antiresorptive agents and their modes of action, to review the proposed mechanisms in the pathophysiology of osteonecrosis development and to analyse the prevention and the management of medication‐related osteonecrosis of the jaw.Materials and methodsThree databases were searched for ...
F. Domah, N. Shah, J. Domah, R. Shah
openaire +3 more sources
Therapeutics and Clinical Risk Management, 2018 Ayaka Inada, Keiko Hosohata, Saki Oyama, Iku Niinomi, Yasuhiro Mori, Yuki Yamaguchi, Mayako Uchida, Kazunori Iwanaga Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka 569-1094, Japan ...
Inada A +7 more
doaj +1 more source
Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview [PDF]
JBMR Plus, 2023 Medication‐related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse effect of antiresorptive medications administered for control of osseous malignancy, osteoporosis, or other bone metabolic diseases.
Sotirios Tetradis +2 more
doaj +2 more sources
Medication-related osteonecrosis of the jaw in a patient with multiple myeloma
Journal of Indian Academy of Oral Medicine and Radiology, 2015 Osteonecrosis of jaws is a common complication of parenteral nitrogen-containing bisphosphonates and recently medication-related osteonecrosis of the jaw (MRONJ) is contributing to the growing number of similar osteonecrosis cases which involve maxilla ...
Nupur Bhardwaj +3 more
doaj +2 more sources
Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model [PDF]
Acta Cirúrgica Brasileira, 2016 PURPOSE : To evaluate a modified experimental model for medication-related osteonecrosis of the jaw (MRONJ) through the upper right central incisor extraction followed by intravenous bisphosphonate administration. METHODS: Forty five rats underwent the
Cláudia Curra +7 more
doaj +3 more sources
Medication-Related Osteonecrosis of the Jaws
JNCI Monographs, 2019 AbstractMedication-related osteonecrosis of the jaw is an oral complication in cancer patients being treated with either antiresorptive or antiangiogenic drugs. The first reports of MRONJ were published in 2003. Hundreds of manuscripts have been published in the medical and dental literature describing the complication, clinical and radiographic signs ...
Cesar A, Migliorati +2 more
openaire +5 more sources